| Active Ingredient | CLOZAPINE |
| Therapeutic Class | ATYPICAL ANTIPSYCHOTICS |
| Indications |
Schizophreniain patients unresponsive to, or intolerant of, conventional antipsychotic drugs. |
| Caution | Anorexia; constipation; hypersalivation; malaise; speech disorders; urinary incontinence. |
| Dose Range | Adult:12.5 mg once or twice on the first day followed by 25 mg once or twice on the second day. Daily dosage may be increased gradually in step s of 25 to 50 mg. Maximum 900 mg per day . Adult 60 years and over: dose increments should be restricted to 2 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |